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Fullerenes are molecules that, due to their unique structure, have very specific chemical properties which offer them very wide
array of applications in nanomedicine. The most prominent are protection from radiation-induced injury, neuroprotection, drug
and gene delivery, anticancer therapy, adjuvant within different treatments, photosensitizing, sonosensitizing, bone reparation,
and biosensing. However, it is of crucial importance to be elucidated how fullerenes immunomodulate human system of defense.
In addition, the most current research, merging immunology and nanomedicine, results in development of nanovaccines, which
may represent the milestone of future treatment of diseases.
1. Introduction
The aim of this review is to report the most recent progress
on applications of fullerene C
60
and its derivatives in
nanomedicine, as well as the influence of fullerene nanopar-
ticles on immune system. Being novel substances, fullerenes
generate considerable interest particularly in terms of their
toxicity, biokinetics, biodegradation, and possible immune
responses.This paper emphasizes the fullerene’s antioxidative
properties, but also its prooxidative features, as well as the
impact of fullerenes on the cells of innate and adaptive
immunity.
The fullerene C
60
due to its physicochemical properties
has the ability to both scavenge and generate reactive oxygen
species. Antioxidant capacity of C
60
is based on highly delo-
calized 𝜋 double bond system functioning as a “free radical
sponge” and quenching different free radical species more
efficiently than conventional antioxidants [1, 2]. Fullerenes
may also induce prooxidant effects and this is likely to be
dictated by the fullerene in question, the cell type being
investigated, and the experimental setup [3–6].The solubility
of C
60
in polar solutions is very low, which greatly limits
its potential applications in medicine. However, due to the
presence of double bonds, C
60
can be easily modified with
chemical groups that allow its better water solubility. In that
way, water-soluble C
60
derivatives expand their opportunities
for various medical applications such as protection from
radiation-induced injury, neuroprotection, drug and gene
delivery, therapy against many diseases and processes, photo-
sensitizing, sonosensitizing, bone reparation, and biosensing.
2. Protection from Radiation-Induced Injury,
Ionizing Radiation, and UVA
The main event during exposure of living organisms to
ionizing radiation is DNA damage and formation of DNA
double-strand breaks. Two mechanisms are involved: direct
damage of DNA by the radiation energy or indirect damage
mediated through reactive oxygen species such as radicals,
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peroxides, and superoxides, produced during the water
radiolysis. In the case of gamma radiation and X-rays,
where low linear energetic transfer is present, a predominant
proportion of the radiation damage results from the indirect
mechanism. Fullerenol C
60
(OH)
24
has been proven to be
promising protector against ionizing radiation. Stankov et al.
have shown better cell survival in fullerenol-pretreated
irradiated leukemic cells and significant overexpression of
antiapoptotic Bcl-2 and Bcl-xL genes as well as antioxidative
cytoprotective genes such as GSTA4, MnSOD, NOS, CAT,
and HO-1 [7]. Unlike ionizing radiation, UVA radiation
has far less energy but it also affects cells in an oxygen-
dependent manner. Cellular targets are various including
DNA, proteins, and membranes. 8-Oxo-7,8-dihydroguanine
has been identified in several cell types as the major DNA
oxidation product of UVA radiation [8]. This ubiquitous
DNA oxidation product can be produced by hydroxyl rad-
ical (∙OH), singlet oxygen (1O
2
), one-electron oxidants, or
peroxynitrite [9]. In the research of Eropkin and coworkers,
different forms of fullerenols demonstrated dual activity.
Fullerenols C
60
(OH)
18–24 and C60(OH)30–38 showed a pro-
tective effect against UVA-induced phototoxicity as well as
broad spectrum of antiviral activity in vitro against actual
strains of human influenza virus A(H1N1) and A(H3N2),
avian influenza A(H5N1), human herpes simplex virus,
adenovirus, and respiratory-syncytial virus. Fullerenols did
not show toxic effects toward human and animal cells of
various tissue origins [10]. Kato et al. have used fullerene-
C
60
/liposome complex as UVA protector. The complex of
250–500 ppm restored HaCaT keratinocytes viability after
the UVA-irradiation of 10 J/cm2. According to fluorescent
immunostaining, C
60
was mainly located around the outside
of nuclearmembranewithout impairment of cellmorphology
[11]. Further, the complex was administered on the surface
of three-dimensional human skin tissue model, rinsed out
before each UVA-irradiation at 4 J/cm2, and thereafter added
again, followed by 19-cycle repetition for 4 days (sum:
76 J/cm2). Skin damage involved breakdown of collagen type
I/IV, DNA strand cleavage, and pycnosis/karyorrhexis and
was significantly reduced by the complex [12].
3. Neuroprotection
Oxidative stress on nervous tissue can produce damage
by several interacting mechanisms, including increases in
intracellular free Ca2+ and release of excitatory amino acids as
well as excessive production of reactive oxygen species in the
presence of “catalytic” iron or copper ions. Free radical reac-
tions are also involved in the neurotoxicity of aluminum and
in damage to the substantia nigra in patients with Parkinson’s
disease [13]. Oxidative stress generated in this regard causes
physical damage to neurons by demyelination, mitochon-
drial dysfunction, microtubular damage, and apoptosis [14].
Ameliorating properties of fullerene derivatives on acetyl-
cholinesterase (AChE) inhibition induced by organophos-
phates have been investigated by Ehrich and coworkers [15].
Organophosphorus compounds (OP) are widely used as
insecticides and their primary mechanism of action is inhi-
bition of AChE which is followed by cholinergic poisoning.
Rapid AChE inhibition occurring after OP exposure has
been reported to result in oxidative stress, as indicated by
reduction in glutathione, increases in reactive oxygen species,
and production of stress proteins [16]. Ehrich et al. used hen
brain and human neuroblastoma SH-SY5Y cells as model
systems. Cells were incubated with eight different derivatized
fullerene compounds before challenge with paraoxon or
diisopropylphosphorofluoridate (DFP). Activities of brain
and SH-SY5Y AChE with OP compounds alone ranged from
55 to 83% lower than nontreated controls after paraoxon and
from 60 to 92% lower than nontreated controls after DFP.
Most of the incubations containing 1 and 10 𝜇M fullerene
derivatives brought AChE activity closer to untreated con-
trols, with improvements in AChE activity. The fullerene
derivatives demonstrated significant antioxidant capability
in neuroblastoma cells at 1 𝜇M concentrations. No fullerene
derivative at 1 𝜇M significantly affected neuroblastoma cell
viability [15]. The other group has generated nanocomplex
of fullerene C
60
formulated with poly(N-vinyl pyrrolidine)
(PVP) or poly(2-alkyl-2-oxazoline)s (POx) homopolymer
and random copolymer. Tracking of the selected formula-
tions during cellular uptake and their intracellular distribu-
tion were performed in catecholaminergic neurons. C
60
-POx
and C
60
-PVP complexes exhibited similar physicochemical
properties and antioxidant activities. C
60
-POx complex, but
not C
60
-PVP complex, was efficiently taken up by neurons
and attenuated the increase of intraneuronal superoxide
induced by angiotensin II stimulation [17].
Bearing in mind that free radical injury has been specif-
ically implicated in the pathogenesis of different neurode-
generative disorders, Vorobyov and coworkers have used
amyloid-𝛽 (A𝛽) rat model of Alzheimer’s disease (AD) to
study the effects of hydrated fullerene C
60
(C
60
HyFn). Inter-
relations between EEG frequency spectra from the frontal
cortex and the dorsal hippocampus (CA1) were considered.
Infusion of A𝛽1–42 protein into the CA1 region two weeks
before EEG testing decreased hippocampal theta predomi-
nance and eliminated cortical beta predominance observed
in baseline EEG of rats infused with saline or with C
60
HyFn
alone. In contrast, these A𝛽1–42 effects were eliminated in
rats pretreated with C
60
HyFn. Further, to clear up the role
of dopaminergic mediation in AD, peripheral injection of a
dopamine agonist, apomorphine, was applied. In rats infused
with C
60
HyFn or A𝛽1–42 alone, APO attenuated the cor-
tical beta predominance while pretreatment with C
60
HyFn
decreased the apomorphine effect in the A𝛽1–42-treated rats.
Altogether, intrahippocampal injection of A𝛽1–42 dramati-
cally disrupts cortical versus hippocampal EEG interrelations
and pretreatment with C
60
HyFn eliminates this abnormality
[18]. In another model against 𝛽-amyloid- (A𝛽)(25–35-)
induced toxicity toward Neuro-2A cells, scientists investi-
gated C
60
fullerene derivative incorporating poly(ethylene
glycol) (PEG-C(60)-3) and its pentoxifylline-bearing hybrid
(PTX-C(60)-2). PEG-C(60)-3 and PTX-C(60)-2 significantly
reduced A𝛽(25–35-) induced cytotoxicity, with comparable
activities in decreasing reactive oxygen species and main-
taining the mitochondrial membrane potential. A𝛽(25–35)
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treatment caused adenosine monophosphate-activated pro-
tein kinase-associated autophagy. Cytoprotection by PEG-
C(60)-3 and PTX-C(60)-2 was partially diminished by an
autophagy inhibitor, indicating that the caused autophagy
and antioxidative activities protected cells from A𝛽 damage
[19].
Glutamates are the carboxylate anions and salts of glu-
tamic acid. Glutamate is the most abundant excitatory
neurotransmitter which in higher concentration results in
excitotoxicity causing degeneration of neurons and their
death. Glutamate binds to metabotropic glutamate receptors
(mGluRs) and triggers a signaling cascade. Detrimental role
of group II mGluRs during hypoxic conditions has been
described [20]. Giust et al. suggested that [60]fullerene
hydrosoluble derivative through modulation of mGluRs
could be protective against hypoxia. They used human neu-
roblastoma cells (SH-SY5Y) to evaluate the long time (24, 48,
and 72 hours) effects of the trans-3 isomer of [60]fullerene
(t3ss). Low oxygen concentration (5% O
2
) caused cell death,
which was avoided by t3ss exposure in a concentration
dependent manner [21].
Knowing that neural cells are terminally differentiated
and that damaged neurons are difficult to regenerate, C
60
derivatives could be helpful in solving this problem. In
the study of Tsumoto and coworkers, water-soluble C
60
derivatives are shown to have an enhancing effect on the
neurite outgrowth. They used rat pheochromocytoma PC12
cells as a model of nerve cells. PC12 cells were treated with
neurite growth factor (NGF) resulting in the induction of
differentiation and the formation of neurites. Firstly, it was
examined whether or not C
60
derivatives have similar activity
to NGF. However, no effects as seen withNGFwere observed.
Next, the effect of C
60
derivatives on neurite outgrowth
in NGF-treated PC12 cells was examined. PC12 cells that
were treated with NGF plus 0–50 𝜇M C
60
derivative formed
neurites and both neurite number and length of outgrowth
increased in a dose-dependent manner, reaching amaximum
at 25 𝜇M [22].
4. Drug Delivery
Designing multifunctionalized C
60
systems able to be effi-
ciently targeted to specific tissues, cross cell membranes, and
delivery active agents is still an attracting challenge which
involves multidisciplinary approach. In the study of Zhang
and coworkers was developed a new kind of active targeting.
Hyaluronic acid (HA) was grafted onto C
60
and then com-
bined with transferrin (Tf) to obtain a multifunctional drug
delivery system (HA-C
60
-Tf) with significant tumour target-
ing efficacy as well as capacity for photodynamic therapy.
After this step, artesunate (AS) was adsorbed on HA-C
60
-Tf.
MCF-7 cells and tumour-bearing murine model were used to
evaluate antitumour efficacy. AS-loaded HA-C60-Tf showed
enhanced antitumour efficacy in comparison with free AS in
both cases. Furthermore, with laser irradiation in vivo, the
relative tumour volume (V/V0) of HA-C
60
-Tf/AS declined by
half [23].
5. Therapeutic Agents
5.1. Antioxidant. Fullerenol (C
60
(OH)
24
nanoparticles, FNP)
is a symmetrical derivative of C
60
with good water solubility.
In aqueous solutions, it is in the form of poly anionic
nanoparticles whose size distribution is in range between
20 nm and 200 nm with the largest number of measurements
between 30 nm and 100 nm [24]. Srdjenovic et al. have
determined its size distribution and 𝜁-potential in cell culture
RPMI 1640 medium supplemented with 10% fetal bovine
serum (FBS). According to their results, the size distribution
of FNP nanoparticles was not affected by FBS and/or cell
medium and formation of large particles was not induced
but caused reduction in 𝜁-potential of nanoparticles (from
−58mV to −7,9mV). The researchers also investigated the
influence of FNP on Chinese hamster ovary cells (CHO-K1)
survival, as well as antioxidant capacity of FNP in mitomycin
C-treated cell line. It has been shown that activity of antiox-
idative enzymes was increased in dose-dependent manner.
Further results confirmed that FNP did not induce genotoxic
effects; on the contrary, antigenotoxic effects of FNP were
confirmed in the experiment done onMMC-damaged CHO-
K1 cells in concentrations of 11–221.6𝜇M [25]. Fullerenol
with its antioxidant activity can also mediate oxidative stress-
induced senescence. Retinal pigment epithelium (RPE) cells
and ARPE-19 cells were exposed to pulsed H
2
O
2
stress for
5 days. Fullerenol protected the RPE cells, as it reduced the
number of senescence positive cells, alleviated the depletion
of cellular antioxidants, and reduced genomic DNA damage
[26].
The results of Bal et al.’s study provide preliminary indi-
cation that hydrated nanoparticles of pristine C
60
display the
superior antioxidant activity necessary to effectively alleviate
diabetic complications by elimination of testicular apoptosis
and consequent histopathological abnormalities, thus result-
ing in elevation of testosterone level and increase of sperm
content andmotility [27]. In a quite different study, Baati et al.
wanted to find out whether the lifespan can be prolonged.
They administered C
60
dissolved in olive oil (0.8mg/mL)
orally at reiterated doses (1.7mg/kg of body weight) to rats
and demonstrated that it did not entail chronic toxicity but
it almost doubled their lifespan. The effects of C
60
olive oil
solutions in an experimentalmodel ofCCl
4
intoxication in rat
strongly suggested that the effect on lifespan is mainly due to
the attenuation of age-associated increase in oxidative stress
[28]. Antioxidant properties of fullerene derivatives have
also been examined in studies of hair loss. Patients suffering
different conditions such as alopecia, chemotherapy, and
reactions to various chemicals could benefit from these
findings. Zhou et al. [29] reported that fullerene derivatives
accelerated the hair growth in mice and human skin. In addi-
tion, thesemolecules significantly increase the number of hair
follicles. Finally, the most recent paper on the treatment of
liver injury with C
60
derivative tells us that interest in
fullerene application is still high [30].
5.2. Antitumour and Antimetastatic Agent. Modulation of
oxidative stress in tumour tissues, inhibition of the formation
of angiogenesis factors, and subsequent reduction in tumour
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vessel density and the nutrient supply to tumour cells could be
importantmechanisms bywhich fullerenol C
60
(OH)
20
aggre-
gates inhibit tumour growth and suppress carcinoma metas-
tasis in vivo [31]. In the case against KSHV-associated primary
effusion lymphoma (PEL), seven water-soluble fullerene
derivatives were investigated as potential drug candidates.
It was discovered that pyrrolidinium fullerene derivative,
1,1,1󸀠,1󸀠-tetramethyl [60]fullerenodipyrrolidinium diiodide,
induced apoptosis of PEL cells. Pyrrolidinium fullerene treat-
ment significantly reduced the viability of PEL cells compared
with KSHV-uninfected lymphoma cells and induced the
apoptosis of PEL cells by activating caspase-9 via procaspase-
9 cleavage [32]. The results of Hu et al. suggested that folacin
C
60
derivative has the potential to prevent oxidative stress-
induced cell death without evident toxicity. The folacin C
60
derivative self-assembled to form spherical aggregates in
water. Because the compoundwas amphiphilic, it could pene-
trate the cell membrane and protect PC12 cells against hydro-
gen peroxide-induced cytotoxicity [33, 34].Methanofullerene
derivative [60] bearing four carboxylic groups, whose sodium
and potassium salts are water soluble, is compound that has
been confirmed to possess antiviral and anticancer activity
as well as pronounced antioxidant properties in combination
with a low toxicity. The anticancer activity was assessed on
murine leukemia P388 tumour-bearing mice. Antiviral
activity of 1-Na was investigated against HIV-1 and HIV-2
and showed comparable activity against both virus strains
[35].
5.3. Photosensitizers and Sonosensitizers. Photodynamic
therapy (PDT) is light-based therapy which is a nonsurgical
procedure, with minimally invasive approach that has been
used in the treatment of many solid cancers as well as other
diseases [36]. PDT requires the simultaneous presence of a
photosensitizer, oxygen, and light. Fullerenes possess
some of the advantages in comparison to the other types of
photosensitizers: (1) they are comparativelymore photostable
and demonstrate less photobleaching when compared with
tetrapyrroles and synthetic dyes; (2) fullerenes show both
kinds of photochemistry comprising free radicals and singlet
oxygen while tetrapyrroles demonstrate largely singlet
oxygen; (3) fullerenes can be chemically modified for tuning
the drug’s partition coefficient and 𝑝𝐾a values for the
variation of in vivo lipophilicity and the prediction of their
distribution in biological systems; (4) to enhance the overall
quantum yield and the ROS production and to extend their
absorption spectrum further into the red wavelengths, a
light-harvesting antennae can be chemically attached to
C
60
; (5) molecular self-assembly of fullerene cages into
vesicles allow improved drug delivery and can produce
self-assembled nanoparticles that may have different tissue-
targeting properties [37]. Radical scavenging studies using
the 1,1󸀠-diphenyl-2-picrylhydrazyl radical showed that C
60
in
combination with human serum albumin (C
60
/HSA) had an
increased antioxidant activity, compared to HSA alone.
Further, C
60
/HSA efficiently generated not only superoxide
anion radicals O2
∙− but also singlet oxygen 1O
2
through
photoirradiation. C
60
/HSA showed A549 cell toxicity
characteristics after light irradiation, but no toxicity was
observed in the absence of irradiation. In this way, C
60
/HSA
not only has an excellent stability and antioxidant activity
but also has considerable phototoxicity properties [38]. Ikeda
et al. have investigated the cationic C
60
derivative⋅𝛾-CDx
complex and showed that it had higher photodynamic ability
than pristine C
60
because the complex possessed the ability to
generate high levels of 1O
2
and provided a higher level of
intracellular uptake. The photodynamic activity of this
complex was also greater than photofrin, which is the most
widely used clinical photosensitizer [39]. The other cationic
derivative of C
60
was examined in vivo by Lu et al. They used
C
60
functionalized with three dimethylpyrrolidinium groups
(BF
6
) which had been shown as highly active broad-spectrum
antimicrobial photosensitizer in vitro when combined with
white-light illumination. In the in vivo study, two mouse
models of infected wounds, potentially lethal, were used.
An excisional wound on the mouse back was contaminated
with one of two stable bioluminescent Gram-negative
species, Proteus mirabilis and Pseudomonas aeruginosa. A
solution of BF
6
was placed into the wound followed by
delivery of up to 180 J/cm2 of broadband white light (400–
700 nm). In both cases, there was a light-dose-dependent
reduction of bioluminescence from the wound, not
observed in control groups (light alone or BF
6
alone).
Fullerene-mediated photodynamic therapy of mice infected
with P. mirabilis led to 82% survival compared with 8%
survival without treatment. Photodynamic therapy of mice
infected with highly virulent P. aeruginosa did not lead to
survival, but when photodynamic therapy was combined
with a suboptimal dose of the antibiotic tobramycin (6mg/kg
for 1 day) there was a synergistic therapeutic effect with a
survival of 60% compared with a survival of 20% with
tobramycin alone [40].
Nanomaterials with multifunctional characteristics such
as, for cancer diagnosis, PDT, radiofrequency, thermal ther-
apy, and magnetic targeting applications have become more
and more popular in nanomedicine. One such hybrid is
the nanocomposite synthesized via decorating iron oxide
nanoparticles (IONP) onto fullerene (C
60
) and then function-
alized by polyethylene glycol (PEG2000), giving C
60
-IONP-
PEG excellent stability in physiological solutions. Hemato-
porphyrin monomethyl ether (HMME), a new photody-
namic anticancer drug, was conjugated to C
60
-IONP-PEG,
forming a C
60
-IONP-PEG/HMME drug delivery system,
which showed an excellent magnetic targeting ability in
cancer therapy. Compared with free HMME, remarkably
enhanced photodynamic cancer cell killing effect using C
60
-
IONP-PEG/HMMEwas realized not only in cultured B16-F10
cells in vitro but also in an in vivomurine tumour model due
to 23-fold higher HMME uptake of tumour and strong pho-
todynamic activity of C
60
-IONP-PEG [41]. In another study
by Shi and coworkers, folic acid (FA), a widely used tumour
targeting molecule, was linked to C
60
-IONP-PEG in order
to obtain an active tumour targeting effect to MCF-7
cells and malignant tumour in mice models. C
60
-IONP-
PEG-FA served not only as a powerful tumour diagnostic
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magnetic resonance imaging contrast agent but also as a
strong photosensitizer and powerful agent for photothermal
ablation of tumour. Furthermore, a remarkable synergistic
enhancement of PDT combination with thermal therapy was
also observed during the treatment both in vitro and in
vivo. Moreover, the multifunctional nanoplatform also could
selectively kill cancer cells in highly localized regions via the
excellent active tumour targeting andmagnetic target abilities
[42].
On the other hand, sonodynamic therapy is based on
the sonosensitizing agent (sonosensitizer) and its subsequent
activation by ultrasound irradiation. Yumita et al. have exam-
ined polyhydroxy fullerene (PHF) and the participation of
lipid peroxidation in the mechanism of the sonodynamically
induced antitumour effect. Sarcoma 180 cells were exposed to
2MHz ultrasound in the presence and the absence of PHF.
Significant enhancement of the rates of both ultrasonically
induced cell damage and lipid peroxidation was observed in
the presence of PHF and was positively correlated with PHF.
The enhancement of cell damage and lipid peroxidation with
PHF was suppressed by reactive oxygen scavengers such as
histidine and tryptophan [43].
5.4. Biosensors. A major problem for the application of
biosensors is their reduction of performance caused by the
inactivation of biomolecules. In order to solve this problem,
antioxidant defense systems have been used to reduce the
oxidative damage. In the study of Guo et al., polyhydroxy-
lated fullerene derivatives (C
60
(OH)
𝑥
) were introduced into
hemoglobin (Hb) electrochemical biosensors through layer-
by-layer assembly. Not only have C
60
(OH)
𝑥
provided a
favorable microenvironment to realize the direct electro-
chemistry and electrocatalysis of hemoglobin, but they have
been successfully used as protective compounds to reduce the
oxidant damage caused by the attack of H
2
O
2
as well [44].
5.5. Bone Repair. Fracture healing involves complex pro-
cesses of cell and tissue proliferation and differentiation.
Many players are involved including growth factors, inflam-
matory cytokines, antioxidants, bone breakdown (osteoclast)
and bone building (osteoblast) cells, hormones, amino acids,
and various other nutrients. Traumatic injuries and patho-
logical conditions, such as osteoporosis, osteonecrosis, and
bone tumours, can lead to bone fractures that do not heal
through endogenous mechanisms. Yang et al. have applied
an innovative approach to solve the issue. They used fullerol
as a strong antioxidant to enhance osteogenic differentiation
in adipose-derived stem cells. When incubated together with
osteogenicmedium, fullerenol promoted osteogenic differen-
tiation in a dose-dependent manner. It was also proved that
fullerenol promoted expression of FoxO1, a major functional
isoform of forkhead box O transcription factors that defend
against reactive oxygen species in bone [45]. It was also
shown that fullerenol can be potentially used for prevention
and treatment of corticosteroid-induced osteonecrosis. Liu
et al. evaluated the effect of fullerenol on adipogenic and
osteogenic differentiation of a mouse bone marrow derived
multipotent cell line, D1. Simultaneous treatment of dexam-
ethasonewith antioxidant glutathione or fullerenol decreased
the number of cells containing lipid vesicles. Treatment with
dexamethasone for 7 days resulted in a significant increase in
adipogenic markers peroxisome proliferator-activated recep-
tor gamma and adipocyte protein 2 gene expression. In
addition, decrease in expression of osteogenic markers runt-
related transcription factor 2 and osteocalcin and antiox-
idative enzymes superoxide dismutase and catalase was also
observed. While glutathione and fullerenol both were able
to antagonize the effects of dexamethasone, fullerenol had
a greater effect than glutathione. Cellular reactive oxygen
species increased after dexamethasone treatment, and addi-
tion of fullerenol attenuated this activity which indicated
that fullerenol inhibited adipogenesis and simultaneously
enhanced osteogenesis by marrow mesenchymal stem cells
[46].
5.6. Anti-Inflammatory Agents. Inflammation is a complex
immunovascular response which involves immune cells,
blood vessels, and molecular mediators with the purpose to
eliminate the initial cause of cell injury, to clear out necrotic
cells and tissues, and to initiate their reparation. Symptoms
of inflammation are unpleasant and can include redness,
swollen joint, joint pain, joint stiffness, and loss of joint func-
tion. In chronic inflammation or in autoimmune responses,
the body’s normally protective immune system causes dam-
age to its own tissues and can lead to various diseases such as
different types of arthritis, fibromyalgia, muscular low back
pain, muscular neck pain, lupus erythematosus, and cancer.
Liu et al. have investigated the anti-inflammatory effects of
fullerol on mouse dorsal root ganglia (DRG) under TNF-𝛼
induction. Their results undoubtedly suggested that fullerol
treatment suppresses the inflammatory responses of DRG
and neurons, as well as cellular apoptosis, by decreasing
the level of ROS and enhancing antioxidative enzyme gene
expression [47]. In the study of Dragojevic-Simic et al., they
have compared anti-inflammatory effects of FNP in regard to
amifostine (AMI) and indomethacin (IND). FNP and IND,
dissolved in dimethylsulfoxide, and AMI, dissolved in saline,
were intraperitoneally injected to rats in a dose range of
12.5–75mg/kg, 3–10mg/kg, and 50–300mg/kg, respectively.
The carrageenan-induced rat footpad edema test was used
for anti-inflammatory evaluation. The drugs were given
30min before carrageenan injection. Footpad swelling was
measured 3 hours after carrageenan application. FNP dose
dependently and significantly reduced the extent of footpad
edema, comparable to that of IND and significantly better
than AMI. Histopathological examination confirmed these
results [48].
Dexamethasone (DEX) is a well-known anti-inflam-
matory drug, whose widespread clinical use is restricted
by its serious side effects. By conjugation of DEX with
C
60
, Zhang and coworkers have found that DEX retained the
anti-inflammatory activity while side effects were reduced.
In mouse thymocytes, the cytotoxicity of DEX-C
60
was
significantly lower than that of free DEX and much less
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apoptotic thymocytes were noticed. Interestingly, such reduc-
tion of cytotoxicity and apoptosis were not observed when
equal moles of free C
60
and free DEX were coincubated
with thymocytes, suggesting that the conjugation alters the
signal pathway of DEX. Researchers have also found that
the binding of DEX-C
60
onto glucocorticoid receptor (GR)
was partially blocked in the thymocytes, which resulted in
downregulation of several apoptosis-related genes [49].
Tuftsin (Thr-Lys-Pro-Arg) is a naturally occurring
tetrapeptide which possesses a wide range of biological
activities, including stimulation of phagocytosis,motility, and
chemotaxis of phagocytes, for example, neutrophils, mono-
cytes, and macrophages. However, the degradation of the
peptide in serum, especially caused by leucine aminopep-
tidase, greatly limits its clinical use [50]. To solve this
problem, Xu et al. have come up with the idea to
conjugate fullerene C
60
to tuftsin by covalently linking with
the carboxyl terminal and the amino terminal, respectively.
The two compounds, NH
2
-etuftsineC
60
and C
60
etuftsine-
COOH, were synthesized. The C
60
etuftsin conjugates
showed complete resistance to the leucine aminopeptidase
degradation. At the same time, both of the conjugates showed
more potent stimulation activities than the free tuftsin
in the phagocytosis and chemotaxis of murine peritoneal
macrophages. Moreover, they could upregulate significantly
the MHC II molecule expression on the surface of
macrophages, whereas the free tuftsin shows no such effect.
Finally, both conjugates show no toxicity to macrophages
[51].
Ischemic stroke can be the cause of brain inflammation.
The brain’s kinds of tissue become swollen and the patient
could suffer headache and a fever, as well as more severe
symptoms in some cases. Glucosamine (GlcN), which atten-
uates cerebral inflammation after stroke, was combined with
fullerenol into conjugates (GlcN-F) and their protective
effects regarding stroke-induced cerebral inflammation and
cellular damagewere examined. Fullerene derivatives or vehi-
cle was administered intravenously in normotensive Wistar-
Kyoto (WKY) rats and in spontaneously hypertensive rats
(SHR) immediately after transient middle cerebral artery
occlusion. Treated rats showed an amelioration of neurolog-
ical symptoms as both fullerenol and GlcN-F prevented neu-
ronal loss in the perilesional area. Cerebral immunoreactivity
was reduced in treated WKY and SHR. Expression of IL-
1𝛽 and TLR-4 was attenuated in fullerenol-treated WKY rats
[52].
6. Fullerenes: Misconception or Milestone
of Medicine
It is well established that fullerenes have wide spectrum of
potential and promising applications in medicine. However,
there are many debates about the health and safety issues that
fullerenes may have in biological systems. Existing studies
report inconclusive and conflicting results regarding the
toxicity of fullerene nanoparticles [53]. The first study that
reported oxidative damage in brain and gills of largemouth
bass [54] later on was proven to be unfounded since it did not
include adequate control and could not exclude the effects of
impurities. However, the recent study has demonstrated that
fullerenes may create risk to benthic organisms, particularly
small agglomerates of fullerene [55]. Nakagawa et al. have
revealed that C
60
(OH)
24
induced DNA fragmentation in rat
hepatocytes, which could be prevented with special pretreat-
ment [56]. Furthermore, study that investigated cytotoxic
effects of fullerenol in different cell types concluded that cyto-
toxicity was cell type specific and that cell cycle was arrested
in G1 phase [57]. Saathoff et al. have observed decrease in
viability of human epidermal keratinocytes onlywhen treated
with the highest concentration of C
60
(OH)
32
(used range was
0.000544–42.5 𝜇g/mL, used fullerenols were C
60
(OH)
20
,
C
60
(OH)
24
, and C
60
(OH)
32
) [58]. Surface chemistry and
concentration of fullerene nanoparticles, as well as the cell
type, are the major factors involved in fullerene toxicity.
Development of high-throughput analysis, particularly high-
content screening, will enable the generation of toxicological
data contributing to the safety assessment of fullerene and
its derivatives in biological systems. This will contribute to a
better understanding of potentially hazardous effects in
humans and the environment [59].
7. Fullerenes and Immunity
One of the main focal points is, undoubtedly, fullerenes’
modulation of possible immune responses. However, a large
body of evidence on their influence on immune system is still
missing. Previous study by Chen et al. revealed that C
60
fullerene derivative, conjugated to bovine thyroglobulin,
induced production of fullerene-specific IgG antibodies in
immunized mice [60], demonstrating an ability of adap-
tive arm of immune system to recognize novel chemical
species that were encountered. Similar observation was made
by Braden et al. who reported IgG antibodies specific to
fullerene when it was conjugated to the carrier protein, rabbit
serum albumin (RSA) (Figure 1) [61]. The humoral immune
response protects the extracellular space, and during initial
infection, the adaptive immune system is slow to start but
rapidly excludes the invader when the organism is rechal-
lenged with the same pathogen. However, it remains unclear
whether it is generation of specific antibodies response of
immune system to the fullerene nanoparticle itself or it is
response to the conjugate with the carrier proteins. In the case
of the latter, it is possibly due to the increase in size of
nanoparticle [62].
The first study to investigate interaction between C
60
carboxyfullerene and cells of immune system revealed that
C
60
was able to protect human peripheral bloodmononuclear
cells (PBMCs) from apoptosis, due to a mechanism that
implicated mitochondrial membrane potential integrity [63].
Recent study by Bunz et al. has demonstrated that nei-
ther polyhydroxy-C
60
(poly-C
60
) nor N-ethyl-polyamino-
C
60
(nepo-C
60
) nanoparticles were able to alert adaptive
immunity, since they have had no influence on T cell reactiv-
ity (no T cell proliferation was observed as well as no increase
in T cell cytokine production was noticed) when PBMCs
were treated with these nanoparticles. However, significant
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Figure 1: Response of the cells of innate and adaptive immune system to fullerene. The cells of the innate immune system are the first
to respond. When they encounter the intruder, they become activated and start producing different cytokines, which have direct antiviral
activity (IFN-𝛾, TNF-𝛼), deliver stimulatory signals to other cells of the innate system (IL-12, IL-18), initiate inflammation (IL-1𝛼/𝛽, IL-6),
or act as chemoattractants that recruit inflammatory cells to the site of infection (MIP-1𝛼, IP-10). During this cascade of events, the antigens
are presented to T cells, mainly by DC, which are the professional antigen presenting cells that link the innate and adaptive immune system.
When primed, T cells secrete IL-2, which induces their clonal proliferation and development of effector functions. Differentiated effector
cells, particularly CD8+ T cells, tackle infection and eliminate the virus. B cells can be activated by cells of innate immunity (IL-21) or directly
by antigens, and upon activation they differentiate into plasma cells producing antigen specific antibodies.
increase in production of IL-6 and propagation of CD56+
cells (natural killer cells) indicated that these fullerenes have
activated the part of PBMCs that belongs to the innate
immunity [64]. Innate arm of the immune system is a part
of universal host defense mechanism, present in plants and
animals, with molecular modules having probably evolved
before the division into these two kingdoms [65]. In humans,
when the first line of defense, represented by the physical
barrier of skin and mucosa, is compromised, an antigen
nonspecific response against the pathogen is delivered by
the innate immune system. This system is initiated within
a few minutes following the beginning of infection. The
innate immune system is composed of many serum proteins
(including acute phase proteins and cytokines) and cells,
with phagocytes (macrophages, neutrophils, and dendritic
cells (DC)) and natural killer (NK) cells being essential for
functioning of the system (Figure 1) [66].
Liu et al. have demonstrated, in a murine H22 hepatoma
model, that fullerene derivatives (Gd@C
82
(OH)
22
) were
able to activate T lymphocyte and to increase the ratio of
CD4+/CD8+ T cells, improving anticancer activity. In addi-
tion, they have showed an enhanced production of cytokine
TNF-alpha by macrophages confirming the induction of
complete immune response, both innate and adaptive, and
reducing a tumour neoformation in this model by around
60% [67]. Furthermore, the same group has demonstrated
that water-soluble fullerenol C
60
(OH)
20
nanoparticles have
immunomodulatory ability on both T cells and macrophages
(Figure 1). These nanoparticles increased the Th1 response
(IL-2, IFN-gamma, and TNF-alpha), decreasedTh2 response
(IL-4, IL-5, and IL-6), and were able to increase the pro-
duction of TNF-alpha by T cells and macrophages almost
threefold [68]. Previous study by Zhu et al. has also
revealed fullerenol C
60
(OH)
𝑥
immunomodulatory activity
on macrophages, whose activation busted the innate immu-
nity and therefore considerably inhibited the enlargement of
murine H22 hepatocarcinoma [69].
Interaction between dendritic cells (DC) and natural
killer (NK) cells may be crucial in shaping the innate
response. Namely, DCs activateNK cells via production of IL-
12 and IL-18 or via expression of NK-activating ligands [70].
In addition, DCs are the most important antigen presenting
cells (APC), whose main function is to ingest, process, and
present antigen to T cells, having a crucial role in networking
the innate and adaptive immune responses. Influence of
fullerenes on DC has also been reported (Figure 1). In mouse
model, gado fullerenol (Gd@C
82
(OH)
22
)(n) nanoparticles
induced maturation and activation of DC as well as
enhancement of Th1 immune response (IFN-gamma),
thus providing understanding for great antitumour activity
8 Journal of Nanomaterials
of (Gd@C
82
(OH)
22
)(n) nanoparticles [71]. Interestingly,
a recent study has shown that the same gado fullerenol
nanoparticle could disturb and block proline-richmotif from
binding to SH3 domain, which are rather common in
protein-protein interaction, frequently used during the
establishment of immune or cellular regulatory responses
[72]. Previously, the same group has published observation
that this nanoparticle significantly reduces activity of
matrix metalloproteinases-9 (MMP-9) which contributes to
inhibition of neoplastic growth in human pancreatic cancer
grafts in a nude mouse model. Since MMPs are known
to participate in angiogenesis and variety of immune
interactions, it is expected that suppression of MMP activity
will result in decline of tumour survival and invasion [73].
A gene microarray analysis on zebrafish embryos, mi-
croinjected with a sublethal dose of hydroxylated fullerenes
(C
60
(OH)
24
), demonstrated significant change in expression
of different genes involved in immune response [74]. The
same group, using another fish model (Pimephales promelas)
and using quantitative PCR, has confirmed that hydroxylated
fullerenes caused changes at the mRNA levels of highly
conserved genes involved in innate immunity [75]. A recent
computational study has shown that C
60
fullerenes can act
as ligands for toll-like receptors (TLRs) and therefore can
be recognized as pathogens, inducing proinflammatory
immune response (IL-8, MCP-1) [76]. Additionally, strong
splenic inflammation with increased production of IL-2 and
TNF-alpha was observed in mice spleen tissue [77]. How-
ever, some studies emphasized strong anti-inflammatory
responses of fullerene C
60
. In adjuvant-induced arthritis in
rats [78], C
60
decreased neutrophil phagocytic activity and
production of antinuclear antibodies, resulting in inflam-
mation decline, and also facilitated in restitution of spleen
morphology. Furthermore, inorganic fullerene-like nanopar-
ticles (molybdenum disulfide nanoparticles) significantly
decreased proinflammatory immune response (IL-1beta, IL-
6, IL-8, and TNF-alpha) in nontransformed human bronchial
cells [79].
A very challenging area in immunology is, certainly, vac-
cine development. Anovel approach to combat infectious dis-
eases is evolution of nanovaccines, which will be able to cure
and prevent diseases better than currently used vaccines.
Explicitly, nanoparticles are used to deliver components to
which is desired a specific immune response, to increase
adjuvant activity and to enhance antigenicity of the vaccine
components [62]. A recent study by Xu et al. has proved that
fullerenol nanoparticles can act as virus-like particles and can
be used as the dual-functional nanoadjuvant for HIV DNA
vaccine. Namely, they have proved that this vaccine design
enables innate immune response via activation of multiple
TLRs and their signaling pathways, resulting in decrease of
antigen dosage and frequency in immunization, while keep-
ing immunity levels capable of battling the HIV infection at
an early stage [80]. Hence, fullerenol nanovaccine was able to
trigger desirable immune response and to enhance targeting
of specific components of immune system.
Since nanovaccines have a great potential in site-specific
delivery of antigens, improved bioavailability of antigen
components, and a reduced side effect profile [81], they may
have a major role in the vaccine design in the future. This
is incredibly important, specially for the infections with
currently no available vaccines, which are global health
burden, such as hepatitis C or HIV, distributed worldwide
with a number of infected individuals constantly rising.
8. Conclusion
This review represents an overview of the most relevant pub-
lications on fullerene C
60
and its derivatives applications, with
the anti/prooxidative features being a central to the topic.
Antioxidative properties are implied in majority of observed
phenomena caused by fullerenes (radiation-induced injury
protection, neuroprotection, anti-inflammatory agent, drug
and gene delivery, antitumour therapy, adjuvantwithin differ-
ent treatments, and bone reparation). However, prooxidative
characteristics were utilized in photodynamic and sonody-
namic treatments. Furthermore, fullerenes have potential
to modulate immune cells function leading to effects on
cytokine production, in order to create the cytokine milieu
that is favourable for appropriate immune response.This fea-
ture is explored for vaccine design, but full understanding of
fullerene nanoparticle and immune system interactions are to
be further elucidated. Nevertheless, this promising strategy
in vaccine development is exceptionally valuable in rapid
discovery of new vaccines, as potential tools for therapeutic
and prophylactic purposes.
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